You are here

  • Home
  • Archive
  • Volume 23, Issue 4
  • Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy: First Study From Asia

Article info

Article menu
Download PDFPDF
Cervical Cancer
Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy: First Study From Asia

Authors

  1. Address correspondence and reprint requests to Daya Nand Sharma, MD, Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi 110029 India. E-mail: sharmadn@hotmail.com.

Citation

Sharma DN, Rath GK, Julka PK, et al
Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy: First Study From Asia
International Journal of Gynecologic Cancer 2013;23:705-709.

Publication history

  • Received August 5, 2012
  • First published May 1, 2013.
Online issue publication 
May 01, 2013

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2013 by IGCS and ESGO